vs
Assertio Holdings, Inc.（ASRT）与FIRST CAPITAL INC（FCAP）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是FIRST CAPITAL INC的1.0倍（$13.5M vs $13.5M），FIRST CAPITAL INC同比增速更快（19.0% vs -57.9%），过去两年FIRST CAPITAL INC的营收复合增速更高（13.4% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
First Capital曾用名Future Capital Holdings，是印度一家非银行金融机构，主营债务融资业务。2018年12月，该机构与IDFC银行合并，组建IDFC第一银行，合并前其股票在印度国家证券交易所和孟买证券交易所挂牌上市。
ASRT vs FCAP — 直观对比
营收规模更大
ASRT
是对方的1.0倍
$13.5M
营收增速更快
FCAP
高出76.9%
-57.9%
两年增速更快
FCAP
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $13.5M |
| 净利润 | — | $4.9M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | — |
| 净利率 | — | 36.2% |
| 营收同比 | -57.9% | 19.0% |
| 净利润同比 | — | 49.6% |
| 每股收益（稀释后） | $-4.54 | $1.45 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTFCAP
| Q4 25 | $13.5M | $13.5M | ||
| Q3 25 | $49.5M | $13.3M | ||
| Q2 25 | $29.2M | $12.4M | ||
| Q1 25 | $26.5M | $11.4M | ||
| Q4 24 | $32.2M | $11.3M | ||
| Q3 24 | $29.2M | $10.9M | ||
| Q2 24 | $31.1M | $10.7M | ||
| Q1 24 | $32.4M | $10.5M |
净利润ASRTFCAP
| Q4 25 | — | $4.9M | ||
| Q3 25 | $11.4M | $4.5M | ||
| Q2 25 | $-16.4M | $3.8M | ||
| Q1 25 | $-13.5M | $3.2M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $-2.9M | $2.9M | ||
| Q2 24 | $-3.7M | $2.8M | ||
| Q1 24 | $-4.5M | $3.0M |
营业利润率ASRTFCAP
| Q4 25 | -86.7% | — | ||
| Q3 25 | 23.2% | 41.8% | ||
| Q2 25 | -27.5% | 37.2% | ||
| Q1 25 | -50.0% | 34.2% | ||
| Q4 24 | -41.9% | 34.8% | ||
| Q3 24 | -10.4% | 31.5% | ||
| Q2 24 | -11.6% | 31.1% | ||
| Q1 24 | -13.4% | 33.0% |
净利率ASRTFCAP
| Q4 25 | — | 36.2% | ||
| Q3 25 | 23.1% | 33.8% | ||
| Q2 25 | -56.0% | 30.4% | ||
| Q1 25 | -51.1% | 28.3% | ||
| Q4 24 | — | 28.8% | ||
| Q3 24 | -10.0% | 26.5% | ||
| Q2 24 | -11.8% | 26.5% | ||
| Q1 24 | -13.9% | 28.1% |
每股收益（稀释后）ASRTFCAP
| Q4 25 | $-4.54 | $1.45 | ||
| Q3 25 | $0.11 | $1.34 | ||
| Q2 25 | $-0.17 | $1.13 | ||
| Q1 25 | $-0.14 | $0.97 | ||
| Q4 24 | $-3.28 | $0.97 | ||
| Q3 24 | $-0.03 | $0.87 | ||
| Q2 24 | $-0.04 | $0.85 | ||
| Q1 24 | $-0.05 | $0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $137.8M |
| 总资产 | $267.0M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTFCAP
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务ASRTFCAP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTFCAP
| Q4 25 | $94.0M | $137.8M | ||
| Q3 25 | $105.8M | $132.4M | ||
| Q2 25 | $93.3M | $123.2M | ||
| Q1 25 | $108.5M | $120.1M | ||
| Q4 24 | $121.1M | $114.6M | ||
| Q3 24 | $130.5M | $116.8M | ||
| Q2 24 | $132.2M | $107.8M | ||
| Q1 24 | $134.5M | $105.7M |
总资产ASRTFCAP
| Q4 25 | $267.0M | $1.3B | ||
| Q3 25 | $319.8M | $1.2B | ||
| Q2 25 | $273.8M | $1.2B | ||
| Q1 25 | $286.4M | $1.2B | ||
| Q4 24 | $284.7M | $1.2B | ||
| Q3 24 | $276.0M | $1.2B | ||
| Q2 24 | $279.4M | $1.2B | ||
| Q1 24 | $282.0M | $1.2B |
负债/权益比ASRTFCAP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $21.3M |
| 自由现金流经营现金流 - 资本支出 | — | $19.9M |
| 自由现金流率自由现金流/营收 | — | 147.7% |
| 资本支出强度资本支出/营收 | — | 10.0% |
| 现金转化率经营现金流/净利润 | — | 4.36× |
| 过去12个月自由现金流最近4个季度 | — | $35.3M |
8季度趋势，按日历期对齐
经营现金流ASRTFCAP
| Q4 25 | $-30.0M | $21.3M | ||
| Q3 25 | $-4.8M | $7.9M | ||
| Q2 25 | $19.1M | $3.7M | ||
| Q1 25 | $-12.5M | $4.4M | ||
| Q4 24 | $11.5M | $22.3M | ||
| Q3 24 | $-35.0K | $7.6M | ||
| Q2 24 | $7.4M | $3.5M | ||
| Q1 24 | $7.5M | $7.2M |
自由现金流ASRTFCAP
| Q4 25 | — | $19.9M | ||
| Q3 25 | — | $7.8M | ||
| Q2 25 | — | $3.5M | ||
| Q1 25 | — | $4.2M | ||
| Q4 24 | — | $21.6M | ||
| Q3 24 | — | $7.5M | ||
| Q2 24 | — | $3.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率ASRTFCAP
| Q4 25 | — | 147.7% | ||
| Q3 25 | — | 58.6% | ||
| Q2 25 | — | 27.8% | ||
| Q1 25 | — | 36.5% | ||
| Q4 24 | — | 190.7% | ||
| Q3 24 | — | 68.6% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | — | 67.2% |
资本支出强度ASRTFCAP
| Q4 25 | — | 10.0% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 1.5% |
现金转化率ASRTFCAP
| Q4 25 | — | 4.36× | ||
| Q3 25 | -0.42× | 1.77× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | — | 1.36× | ||
| Q4 24 | — | 6.84× | ||
| Q3 24 | — | 2.62× | ||
| Q2 24 | — | 1.23× | ||
| Q1 24 | — | 2.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
FCAP
暂无分部数据
